Global Genome Editing/Genome Engineering Market

  • Report Id: VMR 3572
  • Published Date: February, 2020
  • No of Pages: 144
  • Format: Electronic (PDF)
  • Publisher: Verified Market Research
  • Category:

The global Genome Editing/Genome Engineering Market was valued at 4.12 billion in 2019 and is projected to reach USD11.25 billion by 2027, growing at a CAGR of 14.43% from 2020 to 2027.
Genomic engineering is the synthetic assembly of complete chromosomal DNA that is more or less derived from natural genomic sequences. Rising Funds from Govt. and Private sector combined with High demand of Genetic based drugs are expected to boost the market during the forecast period.

Sample Infographics:

Market Dynamics:
1. Market Drivers
1.1 Rising Government Funding and Growth in the Number of Genomics Projects
1.2 Growing Application Areas of Genomics
1.3 Growing Applications of Genome Editing/Genome Engineering
1.4 High Prevalence of Infectious Diseases and Cancer
1.5 Technological developments
1.6 Growth in production of GM Crops

2. Market Restraints
2.1 Lack of Well-trained professionals
2.2 Lack of acceptance for GM Foods
Market Segmentation:
1. Global Genome Editing/Genome Engineering Market, by Application:
1.1 Cell Line Engineering
1.2 Genetic Engineering
1.2.1 Animal Genetic Engineering
1.2.2 Plant Genetic Engineering
1.3 Other Applications

2. Global Genome Editing/Genome Engineering Market, by Technology:
2.1 Crispr
2.2 Talen
2.3 ZFN
2.4 Antisense
2.5 Other Technologies

3. Global Genome Editing/Genome Engineering Market, by End User:
3.1 Biotechnology & Pharmaceutical Companies
3.2 Academic & Government Research Institutes
3.3 Contract Research Organizations

4. Global Genome Editing/Genome Engineering Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Merck
3. Horizon Discovery Group
4. Genscript
5. Sangamo Biosciences
6. Integrated Dna Technologies
7. Lonza
8. New England Biolabs
9. Origene Technologies
10. Transposagen Biopharmaceuticals
11. Editas Medicine
12. Crispr Therapeutics
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Genome Editing/Genome EngineeringMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL GENOME EDITING/GENOME ENGINEERINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GENOME EDITING/GENOME ENGINEERINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION
5.1 Cell Line Engineering
5.2 Genetic Engineering
5.2.1 Animal Genetic Engineering
5.2.2 Plant Genetic Engineering
5.3 Other Applications

6 GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY
6.1 Crispr
6.2 Talen
6.3 ZFN
6.4 Antisense
6.5 Other Technologies

7 GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER
7.1 Biotechnology & Pharmaceutical Companies
7.2 Academic & Government Research Institutes
7.3 Contract Research Organizations

8 GLOBAL GENOME EDITING/GENOME ENGINEERINGMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 – 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 – 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 – 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 – 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

9 GLOBAL GENOME EDITING/GENOME ENGINEERINGMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Merck
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Horizon Discovery Group
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Genscript
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Sangamo Biosciences
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Integrated Dna Technologies
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Lonza
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 New England Biolabs
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Origene Technologies
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Transposagen Biopharmaceuticals
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Editas Medicine
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Crispr Therapeutics
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

11 Appendix
11.1 Related Reports

Choose License Type

Single user
$3,950
Multi User
$4,750
Enterprise User
$6,750
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.